Shoulder Innovations Inc. (NASDAQ:SI) recorded an insider buy on March 13, 2026 when director Richard Buchholz acquired 1,000 shares of the companys common stock at $14.84 per share, for a transaction totaling $14,840.
Following the purchase, Buchholz directly holds 13,666 shares of Shoulder Innovations. The acquisition took place as the shares showed notable recent momentum, gaining 16% over the previous week and trading at $15.12 at the time of the report.
Independent analysis referenced in company reporting indicates the stock appears overvalued relative to its Fair Value. The valuation observation sits alongside a set of operational and market developments that investors may weigh as they assess the name.
Quarterly results and analyst responses
Shoulder Innovations posted fourth-quarter 2025 revenue of $14.4 million, a 65% increase year over year. Despite the revenue gain, the company reported a net loss of $7.8 million for the quarter.
Analyst reaction has been positive on the sales beat. Jefferies raised its price target for Shoulder Innovations to $21.00 from $20.00 and kept a Buy rating, citing sales that exceeded the consensus estimate of $12.8 million. BTIG likewise raised its price target to $24 from $23 and maintained a Buy rating, noting that revenue surpassed both their internal estimate of $12.6 million and consensus expectations.
Loss per share for the period was $0.38, compared with BTIGs estimate of a $0.36 loss and the consensus estimate of a $0.39 loss.
Company commentary and analyst notes attributed the stronger top-line performance to continued growth in implant utilization and the adoption of the companys products by new surgeons, factors cited as contributors to the quarter's revenue outperformance.
What this means for stakeholders
- Insider buying: A director-level purchase increases a senior insiders direct stake to 13,666 shares.
- Market reaction: The stock has moved higher in the short term, with a 16% gain over the last week to $15.12.
- Operational results: Revenue expanded materially year over year, but the company remains unprofitable on a net-loss basis.
The combination of an insider purchase, a near-term share-price advance, a revenue beat, and analyst price-target raises frames the current public narrative around Shoulder Innovations, while valuation and profitability remain active data points for market participants.